Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (21-30 of 621) with videos related to

Pageof 63
Sort By:
Nature Reviews. Rheumatology|April 7, 2019
Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosisGabriela Kania, Michal Rudnik, Oliver Distler
Innere Medizin (Heidelberg, Germany)|December 1, 2025
[Systemic sclerosis : A disease with multiple faces]Caroline Evers, Jörg Distler, Oliver Distler
Nature Reviews. Rheumatology|July 3, 2010
Inflammation: Microparticles and their roles in inflammatory arthritidesJörg H W Distler, Oliver Distler
Annals of the Rheumatic Diseases|May 22, 2007
Cardiotoxicity of imatinib mesylate: an extremely rare phenomenon or a major side effect?Jörg H W Distler, Oliver Distler
Annals of the Rheumatic Diseases|July 23, 2018
Response to: 'Can we further SPARkle the SPAR model?' by Kavadichanda <i>et al</i>Wanlong Wu, Suzana Jordan, Oliver Distler
Lancet (London, England)|May 10, 2016
Tocilizumab for systemic sclerosis: implications for future trialsOliver Distler, Jörg H W Distler
Annals of the Rheumatic Diseases|November 12, 2018
Response to: 'Will SPAR be useful in the usual patients with scleroderma?' by Chattopadhyay <i>et al</i>Wanlong Wu, Suzana Jordan, Oliver Distler
Current Rheumatology Reports|April 23, 2014
Personalized medicine in systemic sclerosis: facts and promisesRucsandra Dobrota, Carina Mihai, Oliver Distler
Annals of the Rheumatic Diseases|June 30, 2026
Response to correspondence on 'The incidence of interstitial lung disease in patients with systemic sclerosis' by Petelytska et alLiubov Petelytska, Oliver Distler, Cosimo Bruni
Medizinische Monatsschrift Fur Pharmazeuten|June 17, 2008
[Systemic sclerosis]Giorgio Tamborrini, Meike Distler, Oliver Distler
Pageof 63

Showing results (21-30 of 621) with videos related to

Sort By:
Pageof 63
Nature Reviews. Rheumatology|April 7, 2019
Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosisGabriela Kania, Michal Rudnik, Oliver Distler
Innere Medizin (Heidelberg, Germany)|December 1, 2025
[Systemic sclerosis : A disease with multiple faces]Caroline Evers, Jörg Distler, Oliver Distler
Nature Reviews. Rheumatology|July 3, 2010
Inflammation: Microparticles and their roles in inflammatory arthritidesJörg H W Distler, Oliver Distler
Annals of the Rheumatic Diseases|May 22, 2007
Cardiotoxicity of imatinib mesylate: an extremely rare phenomenon or a major side effect?Jörg H W Distler, Oliver Distler
Annals of the Rheumatic Diseases|July 23, 2018
Response to: 'Can we further SPARkle the SPAR model?' by Kavadichanda <i>et al</i>Wanlong Wu, Suzana Jordan, Oliver Distler
Lancet (London, England)|May 10, 2016
Tocilizumab for systemic sclerosis: implications for future trialsOliver Distler, Jörg H W Distler
Annals of the Rheumatic Diseases|November 12, 2018
Response to: 'Will SPAR be useful in the usual patients with scleroderma?' by Chattopadhyay <i>et al</i>Wanlong Wu, Suzana Jordan, Oliver Distler
Current Rheumatology Reports|April 23, 2014
Personalized medicine in systemic sclerosis: facts and promisesRucsandra Dobrota, Carina Mihai, Oliver Distler
Annals of the Rheumatic Diseases|June 30, 2026
Response to correspondence on 'The incidence of interstitial lung disease in patients with systemic sclerosis' by Petelytska et alLiubov Petelytska, Oliver Distler, Cosimo Bruni
Medizinische Monatsschrift Fur Pharmazeuten|June 17, 2008
[Systemic sclerosis]Giorgio Tamborrini, Meike Distler, Oliver Distler
Pageof 63